Tennessee Oncology Researchers Help Lead Global Trial of Next-Generation Lung Cancer Therapy
Research Conducted at Tennessee Oncology's Greco-Hainsworth Centers for Research Contributes to Study Showing Longer Overall Survival with Next-Generation KRAS G12C Therapy NASHVILLE, Tenn., Oct. 25, 2026 /PRNewswire/ -- Researchers at Tennessee Oncology served as investigators in a...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.